Decline depth
-39.2%
From rolling 252-day high of $13.74, 122d ago.
Past the 30% Amber threshold.
-39.2%
from rolling 252-day high of $13.74 set 2026-01-12 · 122d ago
Current
$8.36
Decline depth
-39.2%
Decline σ
6.6σ
TFC
3/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Structural break signals
NEO qualifies for the Amber List on decline depth.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Past the 3/5 Watch threshold.
Decline sigma
6.6σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.14% per day).
Past the ≥6σ Amber threshold.
The structural read
What price action says about NEO.
NEO qualifies for the Amber List on decline depth — down -39.2% from its rolling 252-day high.
Cross-confirmation: also showing 3/5 bearish time frames.
Cross-confirmation: decline sigma also reads 6.6σ over 20 bars.
Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 1 (green), weekly 2D (red), monthly 1 (red).
Earnings on file: 2026-02-17. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $4.72
40.4% of range
52W high $13.74
Sector context · Healthcare
182 other Healthcare tickers are on Broken Stocks.
93
Red List
42
Amber
47
Watch
-35.8%
Median decline
Worst in sector: OPRX (-76.7%). Least-bad: ANIP (-20.0%). See all Healthcare listings →
Related — same sector
Closest decliners to NEO
Red List
RARE
Ultragenyx Pharmaceutical Inc.
Red List
TCMD
Tactile Systems Technology, Inc
Amber List Recovering
SPOK
Spok Holdings, Inc.
Amber List Recovering
DMAC
DiaMedica Therapeutics Inc.
Amber List Recovering
RIGL
Rigel Pharmaceuticals, Inc.
Red List
CNMD
CONMED Corporation
Questions about NEO
What people ask.
Why is NEO on Broken Stocks?
NEO qualifies for the Amber List on decline depth. It is down -39.2% from its rolling 252-day high of $13.74, set on 2026-01-12 — 122d ago.
Is NEO a falling knife?
Not by the strict technical definition. NEO is down -39.2% from its 52-week high, but that high was set 122d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. NEO is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.
Is NEO a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is NEO trading inside its 52-week range?
At $8.36, NEO sits 40.4% of the way from its 52-week low ($4.72) to its 52-week high ($13.74). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has NEO been declining?
The current 39.2% decline accrued over 122d, which annualizes to roughly -117.3% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does NEO compare to its sector?
There are 182 other Healthcare tickers on Broken Stocks: 93 Red, 42 Amber, 47 Watch, with 55 showing recovering structural signals. Median sector decline is -35.8% — NEO's decline is deeper than the sector median.
Does NEO's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-02-17) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.